Sign in
4

Changes in Ownership

Chemomab Therapeutics Ltd. Filed Acc 0001178913-22-004100

Director sold 2,409 shares at $2.00 ($4,818)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Neil Harris Director 2022-11-16 Sale −2,409 $2.00 $4,818 10,000 D: show line 1 in the form
Open-market sales · 2,409 sh · avg $2.00 · $4,818

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cohen Neil Harris Director 2022-03-07 Grant or award · Option to Purchase American Depositary Shares +6,820 6,820 D: show line 2 in the form
Cohen Neil Harris Director 2021-04-19 Grant or award · Option to Purchase American Depositary Shares +11,884 11,884 D: show line 3 in the form
Cohen Neil Harris Director 2021-03-16 Grant or award · Option to Purchase American Depositary Shares +688 688 D: show line 4 in the form
Loading xslF345X03/zk2228788.xml…